908 Devices Director Brown Reports $7M+ Stake in Initial Holdings Disclosure
Christopher D. Brown filed an initial Statement of Beneficial Ownership (Form 3) for 908 Devices (MASS) following his appointment as Director.
Rhea-AI Filing Summary
Christopher D. Brown filed an initial Statement of Beneficial Ownership (Form 3) for 908 Devices (MASS) following his appointment as Director. The filing reveals significant equity holdings as of June 13, 2025:
- Direct Common Stock ownership: 962,122 shares
- Stock Options: Total of 320,404 shares at various exercise prices ranging from $1.75 to $16.66, with different vesting schedules
- Restricted Stock Units (RSUs): 52,837 units vesting over four annual installments from 2022-2024
The stock options include both fully vested options and those with future vesting schedules through 2025. RSUs represent contingent rights to receive common stock upon vesting, with no expiration date. This substantial equity position aligns the director's interests with shareholders and indicates a long-term commitment to the company.
Positive
- Director Christopher D. Brown holds significant direct ownership of 962,122 shares of common stock, demonstrating substantial alignment with shareholder interests
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Brown Christopher D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (option to buy) | -- | -- | -- |
| holding | Stock Option (option to buy) | -- | -- | -- |
| holding | Stock Option (option to buy) | -- | -- | -- |
| holding | Stock Option (option to buy) | -- | -- | -- |
| holding | Stock Option (option to buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (option to buy) — 320,404 contracts (Direct);
Restricted Stock Units — 52,837 contracts (Direct);
Common Stock — 962,122 shares (Direct)
Footnotes (8)
- F1. The shares underlying the option are fully vested and immediately exercisable.
- F2. Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2023, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date.
- F3. Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2024, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
- F4. Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2025, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2025, subject to the reporting person's continued service through the applicable vesting date.
- F5. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
- F6. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F7. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
- F8. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
FAQ
What stock options does Christopher Brown hold in MASS?
Christopher Brown holds several stock options in MASS: 114,318 shares at $1.75 (expires 6/22/2027), 67,604 shares at $3.24 (expires 9/21/2030), 33,400 shares at $16.66 (expires 3/1/2032), 45,018 shares at $8.83 (expires 2/28/2033), and 60,064 shares at $7.35 (expires 2/28/2034).
How many Restricted Stock Units (RSUs) does Christopher Brown have in MASS?
Christopher Brown holds three RSU grants totaling 52,837 units: 5,027 RSUs vesting from February 2022, 14,836 RSUs vesting from February 2023, and 32,974 RSUs vesting from February 2024. Each RSU represents one share of common stock upon vesting.
What is Christopher Brown's role at MASS?
According to the Form 3 filing, Christopher Brown serves as a Director of 908 Devices Inc. (MASS).
What is the vesting schedule for Christopher Brown's newest MASS stock options?
The newest stock options (granted 2/28/2034) vest 25% on February 1, 2025, with the remaining 75% vesting in equal monthly installments over 36 months following February 1, 2025, subject to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
